Results 51 to 60 of about 23,898 (157)

Pre-existing Medical Conditions by Antithrombotic Status.

, 2014
Pre-existing Medical Conditions by Antithrombotic Status.
David J. Gemmel (639333), Renee Merrell (639334), Gregory S. Huang (639331), David A. Hoffman (639330), Laurel A. Omert (639332), C. Michael Dunham (302137)   +5 more
core   +1 more source

Flowchart of 194 patients who underwent PTGBD or PTGBA according to the administration of antithrombotic drugs.

, 2023
PTGBD: percutaneous transhepatic gallbladder drainage. PTGBA: percutaneous transhepatic gallbladder aspiration. No drug group: no prior antithrombotic therapy. Discontinuing drug group: antithrombotic drugs discontinuation.
Yasutoshi Nozaki (9073333), Yuki Arimoto (16851402), Takashi Ohta (229611), Shinjiro Yamaguchi (129994), Hideki Hagiwara (6207218), Rui Mizumoto (16851399), Yoshiki Ito (10120287), Takahiro Suda (3854422), Takayuki Iwamoto (190293), Takanori Inoue (16851396)   +9 more
core   +1 more source

Approaches to antithrombotic therapy in elderly patients with atrial fibrillation [PDF]

, 2020
Advanced age is the most important and independent risk factor for the development of atrial fibrillation (AF). The proportion of patients with AF at the age of 65-85 years reaches 70%, and average age of patients with AF is 75 years.
Ushkalova E.A., Zyryanov S.K., Dumchenko E.V.   +2 more
core   +2 more sources

Antithrombotic Treatment in Cardiomyopathies

Current Pharmaceutical Design, 2020
: Cardiomyopathies are a heterogeneous group of heart muscle diseases and important cause of heart failure with reduced or preserved ejection fraction. Although there is an increasing body of evidence on the incidence, pathophysiology, and natural history of heart failure (HF) in cardiomyopathies, certain aspects of the therapeutic strategies remain ...
Georgia Vogiatzi, Antonios Pantazis, Dimitris Tousoulis   +2 more
openaire   +3 more sources

Antithrombotic Therapy in the Elderly

, 2010
Antithrombotic therapy represents the mainstay of treatment for prevention of recurrent ischemic events in patients with atherothrombotic disease processes.
Dominick J. Angiolillo, Davide Capodanno, ANGIOLILLO DJ, CAPODANNO, DAVIDE FRANCESCO MARIA   +3 more
core   +1 more source

Antithrombotic therapy after transcatheter aortic valve replacement

Heart Views, 2022
Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk.
Tariq A.M. Mousa, Ahmed Mahfouz, Nazar Mohammed   +2 more
doaj   +1 more source

Antithrombotic Therapy and Freedom From Bridging Stent Occlusion After Elective Branched Endovascular Repair: A Multicenter International Cohort Study. [PDF]

Based on our study, no antithrombotic therapy is significantly associated with bridging stent occlusion, and no evidence of the superiority of other antithrombotic therapy exists.
Dabravolskaite, Vaiva, Maleux, Geert, Venermo, Maarit, Makaloski, Vladimir, Yazar, Ozan, Mufty, Hozan, Aho, Pekka, Hakovirta, Harri, Bouwmann, Lee, Meuli, Lorenz, Venermo, Maarit; https://orcid.org/, Maleux, Geert; https://orcid.org/, Hakovirta, Harri; https://orcid.org/, Mufty, Hozan; https://orcid.org/, Makaloski, Vladimir; https://orcid.org/   +14 more
core   +2 more sources

Management of Antithrombotic Agents During Emergency Endoscopy for Upper Gastrointestinal Bleeding: A Propensity Score Matching Analysis

Background/Aims: This study is aimed at comparing the outcomes of upper gastrointestinal bleeding (UGIB) during emergency endoscopy between patients taking and not taking antithrombotic agents to inform antithrombotic management. Methods: We conducted a
Fujimoto, Shun, Tanaka, Yuichiro, Ikeda, Kei, Yoshioka, Wataru, Fukami, Shota, Jubashi, Amane, Ishida, Satoshi, Morisaki, Tomohito, Nomura, Tadahiro, Kimura, Shunichiro, Asahi, Ryosuke, Ario, Keisuke, Mizuta, Yumi, Yamaguchi, Daisuke, Yamaguchi, Azuki, Nagatsuma, Goshi, Gondo, Kasumi, Tsunada, Seiji, Shimakura, Akane, Takeuchi, Yuki, Hino, Naoyuki   +20 more
core   +1 more source

Dual antiplatelet therapy and the severity risk of lower intestinal bleeding

Journal of Emergencies, Trauma and Shock, 2017
Background: Dual antiplatelet (Plt) therapy with aspirin and clopidogrel is recommended for up to 1 year following acute coronary syndrome. Many of these cardiac patients are also on anithrombotic therapy like warfarin.
Neal Carlin, Fady Asslo, Raymund Sison, Hamid Shaaban, Walid Baddoura, Faiza Manji, Joseph Depasquale   +6 more
doaj   +1 more source

Management of Antithrombotic in Endoscopic Procedures [PDF]

, 2018
The use of antithrombotic medicine has increased along with the growing number of cardiovascular disease in the world. Endoscopy procedure often done to the patients who use antithrombotic medicine.
Dwi Suseno, Suseno, Dwi, Ari Fahrial Syam, Syam, Ari Fahrial   +3 more
core   +1 more source